jabbrv-ltwa-all.ldf jabbrv-ltwa-en.ldf
TABLE 1 Patient disease and transplant characteristics by whether a patient had an RVI
RVI- RVI+ Overall
(N=127) (N=34) (N=161)
Malignant
Yes 46 (36.2%) 15 (44.1%) 61 (37.9%)
No 81 (63.8%) 19 (55.9%) 100 (62.1%)
T Cell Depletion
Yes 14 (11.0%) 4 (11.8%) 18 (11.2%)
No 113 (89.0%) 30 (88.2%) 143 (88.8%)
Myeloblative Conditioning
Yes 80 (63.0%) 28 (82.4%) 108 (67.1%)
No 47 (37.0%) 6 (17.6%) 53 (32.9%)
Serotherapy
Yes 56 (44.1%) 15 (44.1%) 71 (44.1%)
No 71 (55.9%) 19 (55.9%) 90 (55.9%)
Stem Cell Source
BM 67 (52.8%) 26 (76.5%) 93 (57.8%)
CORD 14 (11.0%) 3 (8.8%) 17 (10.6%)
PBSC 46 (36.2%) 5 (14.7%) 51 (31.7%)
Donor Type
Match 75 (59.1%) 23 (67.6%) 70 (43.5%)
Mismatch 52 (40.9%) 11 (32.4%) 91 (56.5%)
CMV Concordance
No 51 (40.2%) 19 (55.9%) 70 (43.5%)
Yes 76 (59.8%) 15 (44.1%) 91 (56.5%)